CEACAM8 and breast carcinoma: Data on the prognostic role of TANs in breast cancer are mixed and further clarification is needed: Boissiere-Michot et al. reported no prognostic relevance of CD66b+ TANs in a mixed subtype as well as a triple-negative breast cancer (TNBC) cohort [9,10].